Innovhem
Biomarker assays and clinical research services for pharma, biotech and clinicians working on sickle cell disease
Highlights
- New on EvolcAdded 2026-11-12
About Innovhem
Innovhem develops biomarkers and clinical algorithms to assess treatment efficacy and help physicians personalize care for sickle cell disease. Its assays include single-cell fetal hemoglobin quantification and tests related to intravascular hemolysis and sickling.
The company provides research services to pharmaceutical and biotechnology companies, including biomarker development and assay validation for red blood cell pathologies. Its work also supports patient monitoring and treatment development.
Innovhem was founded in 2019 and is based in Évry-Courcouronnes, France. Its team includes research, project management and quality roles.
Product: Biomarker assays, clinical algorithms and custom research services for sickle cell disease and other red blood cell pathologies.
Jobs at Innovhem
Leadership
- PABLO BARTOLUCCI · Co-Founder, CSOSource: company website
- MARIE CAMBOT · Co-Founder, CEOSource: company website
More biotech & pharma companies
Innovi
Research and development laboratory for organizations developing food, nutrition, cosmetics, crop protection and bio-based materialsInorevia
Benchtop walk-away automation for NGS library prep, sold to genomics core labs, clinical labs and biotech R&D teamsNew on EvolcInovarion
Contract biomedical research services for pharma and biotech teams, from discovery and preclinical work to regulatory affairsInovotion
In vivo oncology efficacy and toxicity assays for drug developers and cancer researchersNew on EvolcInserm Transfert
Technology transfer subsidiary of Inserm that commercialises life-science research from French public labsInvenis Biotherapies
Develops platelet-secretome therapies for patients with neurodegenerative diseases and brain injuriesNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- AWSHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-amz-cf-id
- Response headerx-amz-cf-id
- Response headerx-amz-cf-id
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.